← FDA DRUG APPROVALS

FDA ANDA · ANDA086445

TOLBUTAMIDE

Sponsor: PHARMOBEDIENT

APPLICATION
ANDA086445
TYPE
ANDA
ORIGINAL APPROVAL
1979-04-10
LATEST ACTION
2009-11-12
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TOLBUTAMIDEDiscontinued
TOLBUTAMIDE 500MG · TABLET · ORAL

Approval history

2009-11-12Labeling · Supplement 63AP
2001-09-27Labeling · Supplement 59AP
1998-02-25Manufacturing (CMC) · Supplement 57AP
1998-02-05Manufacturing (CMC) · Supplement 58AP
1993-11-03Manufacturing (CMC) · Supplement 56AP
1991-01-23Labeling · Supplement 54AP
1990-01-31Manufacturing (CMC) · Supplement 53AP
1989-08-08Labeling · Supplement 52AP
1987-08-28Manufacturing (CMC) · Supplement 51AP
1984-09-18Manufacturing (CMC) · Supplement 45AP
1982-03-18Manufacturing (CMC) · Supplement 43AP
1979-04-10OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →